Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

Affiliations

• ¹ Faculty of Economics, Università Cattolica del Sacro Cuore, Rome, Italy.
• ² Division of Nephrology, Sant'Anna Hospital, Como, Italy.
• ³ Department of Health Sciences, University of Milan, Milan, Italy.
• ⁴ Market Access and Corporate Affairs, Genzyme, Italy.
• ⁵ Division of Renal Dis and Hypertension, Department of Medicine, University of Texas Houston Medical School, Houston, TX, USA.
• ⁶ Division of Pediatric Nephrology, Department of Pediatrics, University of Texas Houston Medical School, Houston, TX, USA.
• ⁷ Department of Nephrology, School of Medicine, Federico II University, Naples, Italy.
• ⁸ Department of Nephrology, Ospedale A. Landolfi di Solofra, Solofra (AV), Italy. br.diiorio@gmail.com.